Want to see FLGT full AI Analyst Report?
Total Valuation
Fulgent Genetics has a market cap or net worth of $455.38M. The enterprise value is $321.60.
Market Cap$455.38M
Enterprise Value$321.60
Share Statistics
Fulgent Genetics has 27,515,293 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,515,293
Owned by Insiders40.11%
Owned by Institutions1.82%
Financial Efficiency
Fulgent Genetics’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -7.09%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-7.09%
Return on Capital Employed (ROCE)-0.08
Revenue Per Employee245.75K
Profits Per Employee-46.94K
Employee Count1,313
Asset Turnover0.27
Inventory Turnover18.09
Valuation Ratios
The current PE Ratio of Fulgent Genetics is ―. Fulgent Genetics’s PEG ratio is -0.34.
PE Ratio―
PS Ratio2.51
PB Ratio0.73
Price to Fair Value0.73
Price to FCF-6.51
Price to Operating Cash Flow-5.54
PEG Ratio-0.34
Income Statement
In the last 12 months, Fulgent Genetics had revenue of 322.67M and earned -60.51M in profits. Earnings per share was -1.97.
Revenue322.67M
Gross Profit130.88M
Operating Income-91.10M
Pretax Income-70.03M
Net Income-60.51M
EBITDA-45.83M
Earnings Per Share (EPS)-1.97
Cash Flow
In the last 12 months, operating cash flow was -83.70M and capital expenditures -20.09M, giving a free cash flow of -103.79M billion.
Operating Cash Flow-83.70M
Free Cash Flow-103.79M
Free Cash Flow per Share-3.77
Dividends & Yields
Fulgent Genetics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.40
52-Week Price Change-9.86%
50-Day Moving Average19.21
200-Day Moving Average21.36
Relative Strength Index (RSI)49.07
Average Volume (3m)260.33K
Important Dates
Fulgent Genetics upcoming earnings date is Nov 6, 2026, After Close (Confirmed).
Last Earnings DateJul 30, 2026
Next Earnings DateNov 6, 2026
Ex-Dividend Date―
Financial Position
Fulgent Genetics as a current ratio of 6.48, with Debt / Equity ratio of 0.05%
Current Ratio6.48
Quick Ratio6.35
Debt to Market Cap<0.01
Net Debt to EBITDA0.93
Interest Coverage Ratio-1.21K
Taxes
In the past 12 months, Fulgent Genetics has paid -8.39M in taxes.
Income Tax-8.39M
Effective Tax Rate0.12
Enterprise Valuation
Fulgent Genetics EV to EBITDA ratio is -16.71, with an EV/FCF ratio of -6.17.
EV to Sales2.37
EV to EBITDA-16.71
EV to Free Cash Flow-6.17
EV to Operating Cash Flow-7.54
Balance Sheet
Fulgent Genetics has $257.03M in cash and marketable securities with $482.00K in debt, giving a net cash position of $256.55M billion.
Cash & Marketable Securities$257.03M
Total Debt$482.00K
Net Cash$256.55M
Net Cash Per Share$9.32
Tangible Book Value Per Share$30.81
Margins
Gross margin is 35.58%, with operating margin of -28.23%, and net profit margin of -18.75%.
Gross Margin35.58%
Operating Margin-28.23%
Pretax Margin-21.70%
Net Profit Margin-18.75%
EBITDA Margin-14.20%
EBIT Margin-21.68%
Analyst Forecast
The average price target for Fulgent Genetics is $15.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$15.00
Price Target Upside-23.74% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast6.83%
EPS Growth Forecast-69.59%